Metropolitan Life Insurance CO Cytosorbents Corp Transaction History

Metropolitan Life Insurance CO

$253 Million
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$4.05 - $8.11 $47,263 - $94,643	-11,670 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$7.0 - $9.71 $81,690 - $113,315	11,670 New	11,670 $94,000
Q3 2021 Mar 30, 2023	BUY	$7.0 - $9.71 $18,256 - $25,323	2,608 Added 28.78%	11,670 $94,000
Q3 2021 Nov 15, 2021	BUY	$7.0 - $9.71 $81,690 - $113,315	11,670 New	11,670 $95,000
Q2 2021 Aug 16, 2021	SELL	$7.55 - $9.42 $67 - $84	-9 Closed	0 $0
Q1 2021 Jun 26, 2023	BUY	$8.23 - $11.48 $74,580 - $104,031	9,062 New	9,062 $78.7 Million
Q1 2021 Mar 30, 2023	SELL	$8.23 - $11.48 $11,711 - $16,336	-1,423 Reduced 13.57%	9,062 $78,000
Q1 2021 May 14, 2021	SELL	$8.23 - $11.48 $86,217 - $120,264	-10,476 Reduced 99.91%	9 $79,000
Q4 2020 Jun 22, 2023	BUY	$7.65 - $8.98 $80,210 - $94,155	10,485 New	10,485 $83,000
Q3 2020 Jun 26, 2023	BUY	$7.37 - $11.54 $77,274 - $120,996	10,485 New	10,485 $83,000
Q2 2020 Jun 26, 2023	BUY	$6.28 - $10.59 $65,845 - $111,036	10,485 New	10,485 $103,000
Q2 2020 Mar 30, 2023	BUY	$6.28 - $10.59 $12,610 - $21,264	2,008 Added 23.69%	10,485 $103,000
Q2 2020 Aug 14, 2020	BUY	$6.28 - $10.59 $65,845 - $111,036	10,485 New	10,485 $104,000
Q1 2020 Jul 12, 2023	BUY	$3.77 - $7.73 $8,946 - $18,343	2,373 New	2,373 $18.3 Million
Q2 2019 Jul 12, 2023	BUY	$5.92 - $7.78 $50,183 - $65,951	8,477 New	8,477 $56 Million
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.78 $50,183 - $65,951	-8,477 Closed	0 $0
Q1 2019 Jul 13, 2023	BUY	$6.82 - $8.56 $57,813 - $72,563	8,477 New	8,477 $64,000
Q1 2019 Mar 30, 2023	BUY	$6.82 - $8.56 $57,813 - $72,563	8,477 New	8,477 $64,000
Q1 2019 May 16, 2019	SELL	$6.82 - $8.56 $46,423 - $58,267	-6,807 Reduced 44.54%	8,477 $64,000
Q1 2019 May 15, 2019	BUY	$6.82 - $8.56 $33,022 - $41,447	4,842 Added 46.37%	15,284 $1.73 Million
Q4 2018 Jul 13, 2023	BUY	$7.05 - $12.64 $73,616 - $131,986	10,442 New	10,442 $84,000
Q4 2018 Feb 14, 2019	BUY	$7.05 - $12.64 $57,492 - $103,079	8,155 Added 356.58%	10,442 $84,000
Q3 2018 Jul 13, 2023	BUY	$10.95 - $14.8 $114,339 - $154,541	10,442 New	10,442 $135 Million
Q3 2018 Nov 14, 2018	SELL	$10.95 - $14.8 $89,297 - $120,694	-8,155 Reduced 78.1%	2,287 $30,000
Q2 2018 Aug 15, 2018	BUY	$6.9 - $12.35 $72,049 - $128,958	10,442 New	10,442 $0

Others Institutions Holding CTSO

# of Institutions

Shares Held

16.9M

Call Options Held

10.1K

Put Options Held

500

Avenir Corp Washington, DC

2.97M
Shares

$3.53 Million
0.21% of portfolio
Skylands Capital, LLC

2.84M
Shares

$3.38 Million
0.3% of portfolio
Granahan Investment Management, LLC Waltham, MA

2.66M
Shares

$3.17 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

1.95M
Shares

$2.32 Million
0.0% of portfolio
Neuberger Berman Group LLC New York, NY

1.54M
Shares

$1.83 Million
0.0% of portfolio

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account